Healthy Heart-Tesamorelin Pepetide

• Improved Cardiac Function
• Heart Disease
• Blood Pressure Stability
• Weight Management
• Bodyfat Reduction

Dosing Instructions:

Each 2fl oz bottle contains 600 sprays

Small Pets (Under 20#’s)- 5 sprays on food 2-3 times per day

Medium Pets (20-50#’s)-10 sprays on food 2-3 times per day

Large Pets (50#’s and Up)-15 sprays on food 2-3 times per day

PetTides

Healthy Heart- Tessamorelin

Tessamorelin, also known as Egrifta, is a synthetic analogue of growth hormone-releasing hormone (GHRH). It is primarily used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. However, its potential benefits extend beyond this application, particularly concerning heart and cardiac function. Here’s a detailed description of how Tessamorelin can help in improving heart and cardiac function in pets:

Mechanism of Action
Tessamorelin stimulates the pituitary gland to secrete growth hormone (GH), which subsequently increases the levels of insulin-like growth factor 1 (IGF-1) in the body. This GH/IGF-1 axis plays a critical role in various physiological processes, including cardiovascular health. The key mechanisms through which Tessamorelin may benefit cardiac function include:
- **Increased GH and IGF-1 Levels**: These hormones have direct and indirect effects on cardiac cells, improving heart function and structure.
- **Improved Lipid Metabolism**: By reducing visceral fat and improving lipid profiles, Tessamorelin can alleviate the strain on the heart.
- **Enhanced Vascular Function**: GH and IGF-1 can improve endothelial function and vascular health, which are crucial for maintaining healthy blood flow and reducing cardiovascular risk.

Benefits for Heart and Cardiac Function in Pets
1. **Improved Cardiac Output and Function**:
- **Enhanced Contractility**: GH and IGF-1 improve the contractile function of the heart muscle, leading to better cardiac output and efficiency.
- **Cardiac Muscle Health**: These hormones support the maintenance and repair of cardiac muscle cells, potentially reducing the risk of heart failure.

2. **Reduction in Visceral Fat and Improved Lipid Profile**:
- **Decreased Fat Load**: Tessamorelin helps reduce visceral fat, which is associated with decreased cardiac workload and improved heart health.
- **Lipid Regulation**: By improving lipid profiles (reducing LDL and increasing HDL cholesterol), Tessamorelin lowers the risk of atherosclerosis and coronary artery disease.

3. **Enhanced Vascular Health**:
- **Improved Endothelial Function**: GH and IGF-1 improve endothelial function, which is vital for maintaining healthy blood vessels and proper blood circulation.
- **Vasodilation**: These hormones promote vasodilation, which can help reduce blood pressure and improve overall cardiovascular health.

4. **Anti-Inflammatory Effects**:
- **Reduction in Inflammation**: GH and IGF-1 have anti-inflammatory properties that can reduce chronic inflammation in the cardiovascular system, lowering the risk of heart disease.
- **Improved Immune Function**: These hormones help modulate the immune system, potentially reducing inflammatory responses that can damage heart tissues.

5. **Enhanced Metabolic Function**:
- **Improved Glucose Metabolism**: Tessamorelin can improve insulin sensitivity and glucose metabolism, which are crucial for preventing diabetes-related cardiovascular complications.
- **Energy Utilization**: By enhancing overall metabolic function, Tessamorelin supports better energy utilization, reducing the burden on the heart.


 Conclusion
Tessamorelin offers a promising avenue for improving heart and cardiac function in pets. By enhancing GH and IGF-1 levels, it supports cardiac muscle health, reduces visceral fat, improves lipid profiles, enhances vascular function, and reduces inflammation